What Other Weight Loss Drugs Are There Besides Ozempic?

Last reviewed: June 25, 2026

Last updated: June 25, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Ozempic and Wegovy made GLP-1 receptor agonists a household name, yet the weight loss medication landscape extends far beyond these branded options. The FDA has approved multiple mechanisms for chronic weight management, each with distinct pharmacology and dosing profiles. PlexusDx provides access to several clinically-proven alternatives through licensed 503A compounding pharmacies, offering personalized treatment plans based on genetic peptide pathways.

GLP-1 Receptor Agonists: How Semaglutide Compares to Ozempic

Semaglutide is the active ingredient in both Ozempic and Wegovy, meaning the medication itself is identical regardless of brand or compounding status. The primary difference lies in price and accessibility: branded Ozempic often costs $900–$1,300 monthly even with insurance, while PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) without requiring membership or coverage approval. Clinical trials show semaglutide produces an average 15% body weight reduction over 68 weeks, with effects continuing as long as the medication is used consistently.

Compounded semaglutide from licensed 503A pharmacies meets the same pharmaceutical standards as branded versions, using FDA-regulated manufacturing processes and quality controls. The medication works by activating GLP-1 receptors in the brain's appetite centers, slowing gastric emptying, and improving insulin sensitivity. PlexusDx patients access the same mechanism as Ozempic users but without the markup associated with branded pharmaceutical distribution.

Tirzepatide: The Dual-Peptide Alternative for Greater Weight Loss

Tirzepatide activates both GLP-1 and GIP receptors, a dual mechanism that distinguishes it from single-target semaglutide. Clinical data from the SURMOUNT trials demonstrate tirzepatide produces 20–22% average body weight reduction—approximately 5–7 percentage points greater than semaglutide alone. This dual-pathway activation may benefit patients whose genetic profiles show stronger GIP receptor expression or those seeking maximum satiety signaling. PlexusDx offers compounded tirzepatide injection at $289/mo month-to-month, or from $249/mo on the 6-month plan, with doses escalating safely while pricing remains flat.

The GIP receptor pathway triggers additional metabolic responses including improved glucose control and potentially greater appetite suppression in certain genetic backgrounds. Tirzepatide approval data showed sustained weight loss through 2 years of continuous treatment, with cardiovascular benefits documented in patients with existing heart disease or diabetes. PlexusDx's Precision Peptide Genetic Test identifies individual GIP and GLP-1 receptor variants, helping determine whether dual-peptide therapy may deliver superior outcomes for your specific biology.

Oral vs. Injectable Medications: Choosing Your Delivery Method

Injectable GLP-1 and GIP medications deliver rapid systemic absorption, producing consistent blood levels and predictable pharmacodynamics that clinical research has extensively validated. Patients using PlexusDx semaglutide or tirzepatide injections typically experience appetite reduction within 24–48 hours and stable therapeutic levels by week two. Oral formulations require higher doses to overcome hepatic first-pass metabolism, increasing total drug exposure while potentially causing more gastrointestinal side effects in some patients.

PlexusDx offers both oral semaglutide ($289/month) and oral tirzepatide ($349/month) for patients who prefer avoiding weekly injections. Oral medications provide convenience and privacy but demand strict fasting conditions and specific timing relative to meals for optimal absorption. Your PlexusDx provider discusses delivery preferences during consultation, considering your lifestyle, injection comfort, and genetic peptide-response patterns to recommend the approach most likely to succeed long-term.

PlexusDx Precision Peptide Genetic Testing: Personalize Your Therapy

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Ozempic or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Personalized genetic insight means your PlexusDx treatment plan reflects not just clinical averages but your individual receptor sensitivity and metabolic response patterns. Some patients genetically predisposed to GLP-1 receptor sensitivity achieve excellent results with microdose therapy ($129/month), while others benefit from standard or combination approaches. This precision approach reduces trial-and-error prescribing and helps you achieve sustainable weight loss faster by aligning your medication with your peptide biology.

Other Weight Loss Mechanisms: Beyond GLP-1 and GIP Agonists

The broader weight loss medication landscape includes phentermine (an appetite suppressant used since the 1950s), naltrexone/bupropion combinations targeting neural feeding centers, and emerging SGLT2 inhibitors that promote glucose excretion. However, these alternatives lack the robust clinical evidence for sustained weight reduction that GLP-1 and GIP agonists demonstrate, and most cause less sustained weight loss than modern peptide therapies. Phentermine, for example, typically produces 5–7% weight reduction and is approved only for short-term use (12 weeks), whereas semaglutide and tirzepatide show durable results over years.

PlexusDx specializes in GLP-1 and GIP-based compounded medications because clinical evidence most strongly supports these pathways for meaningful, sustainable weight loss. The dual-peptide option, GLP-Squared (combining semaglutide and tirzepatide in one injection), represents cutting-edge personalized treatment available through PlexusDx at $289/mo month-to-month, or from $249/mo on the 6-month plan. Your provider can discuss whether single-peptide, dual-peptide, or oral delivery best matches your clinical profile and life circumstances.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is compounded semaglutide from PlexusDx as safe and effective as brand-name Ozempic?

Compounded semaglutide from licensed 503A pharmacies contains the identical active ingredient, follows the same FDA manufacturing standards, and shows equivalent clinical efficacy. The key difference is cost: PlexusDx delivers compounded semaglutide at $189/month without insurance, versus $900–$1,300+ for branded Ozempic. Both products work through the same GLP-1 receptor mechanism and produce similar weight loss outcomes when dosed appropriately.

What percentage of body weight can I expect to lose with tirzepatide versus semaglutide?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Does PlexusDx accept insurance, and are these medications HSA/FSA eligible?

PlexusDx requires no insurance and charges no membership fees, making compounded medications accessible to uninsured and underinsured patients. All PlexusDx peptide therapies are HSA/FSA eligible, reducing your out-of-pocket cost further if you maintain these health savings accounts. Your dose may need to go up; your price won't—PlexusDx pricing remains flat across all commitment tiers.

What are the most common side effects of GLP-1 medications, and how long do they last?

Nausea, vomiting, constipation, and reduced appetite are most frequent, typically appearing in the first 1–2 weeks and diminishing as your body adapts. Most side effects resolve within 4–6 weeks as tolerance builds; slower dose escalation reduces their severity. Serious adverse events are rare but include pancreatitis and gallbladder issues in susceptible individuals—reasons your PlexusDx provider screens for contraindications before starting therapy.

What does the PlexusDx Precision Peptide Genetic Test actually measure, and how does it improve my treatment?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Weight Loss Drugs Like Ozempic
• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Ozempic Weight Loss Before And After Pictures

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.